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Acronyms 
 
ACT – acceptant and commitment therapy 
ALT – alanine aminotransferase 
AN-ERP – exposure response prevention for anorexia 
APA – American Psychiatric Association 
ARFID – avoidant/restrictive food intake disorder 
AST – aspartate aminotransferase 
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BMI – body mass index 
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CBT – cognitive behavior therapy 
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DBT – dialectical behavior therapy 
ED – eating disorders 
ERP-B – exposure response prevention for binging 
ERP-P – exposure response prevention for purging 
FSH – follicle stimulating hormone 
GAPS – Guidelines for Adolescent Preventative Services 
HAES – health at every size 
HVA – homovanillic acid 
IBW – ideal body weight 
IE – intuitive eating 
IGF-1 – insulin-like growth factor 1 
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IPT – interpersonal therapy 
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LOC – levels of care 
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MED- DBT – multi-diagnostic complex eating disorder dialectical behavior therapy 
MRI – magnetic resonance imaging 
NICE – National Institute for Health and Clinical Excellence 
NPY – neuropeptide Y 
OCD – obsessive compulsive disorder 
OSFED – other specified feeding or eating disorder 
PHP – partial hospitalization program 
PYY – peptide tyrosine tyrosine 
PTSD – post traumatic stress disorder 
RANZCP – Royal Australian and New Zealand College of Psychiatrists 
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RD – registered dietitian 
RMR – resting metabolic rate 
RO-DBT – radically-open DBT 
SUD – substance use disorder 
SSRI – serotonin re-uptake inhibitor 
TCAs - Tricyclic antidepressants   
UFED – unspecified feeding or eating disorder 
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Introduction 
 
Eating disorders (ED) are characterized by severe disturbances in eating behavior and body 
weight.1  They encapsulate a broad range of compulsive food and eating related disturbances 
that are considered one of the more malicious psychiatric disorders.2  Disturbances may include 
persistent dietary restraint, starvation, low weight, overvaluation of body shape, body 
dysmorphia, periodic overeating, purging, overweight, and aversion to food based on sensory 
and texture aversions.2  The etiology of eating disorders is multi-factorial including genetic, 
biological, individual, family, psychological, and socio-cultural and as such require a multi-
disciplinary treatment approach.3   
 
EDIN: Education and Insight on Eating Disorders, is a local non-profit working to create 
awareness and provide education on eating disorders to those struggling with EDs, caregivers, 
and medical and therapeutic professionals in the metro Atlanta area.  Currently, they offer a 
wide variety of educational resources including in-person and web-based presentations and 
educational curriculum.  The purpose of this literature review is to explore the current research 
on eating disorders including, but not limited to, prevalence, etiology, metabolism, 
neurochemistry, and the multi-disciplinary roles of the treatment team.  The ultimate goal of 
this capstone project is to provide a comprehensive and educational video aimed at improving 
ED knowledge in the professional community. 
Eating Disorder Prevalence 
 
National and global studies indicate an increase in the overall prevalence of ED over recent 
years.1  It is estimated that up to 70 million individuals worldwide and 30 million individuals in 
the United States will have an eating disorder during their lifetime.4-6  In Georgia, there are 
around 339,500 people who suffer from ED.7  In both Canada and the United Kingdom, it is 
estimated that ED are third highest chronic condition among girls ages 15-19 years old.2,8  
Although ED are traditionally thought to be confined to Western countries, studies have 
highlighted a higher prevalence in Asia and developing Middle-Eastern countries.1  ED affect all 
ages, genders, ethnicities, and sexualities.  Approximately 95% of initial cases in both males and 
females occurred by the age of 25, with the highest mean annual prevalence around the age of 
21 years.9  Although the estimated annual prevalence of ED is lower comparative to other 
disease states, the cumulative lifetime burden is high at 14.3% for male and 19.7% for female 
individuals.9  The stereotypical ED patient is an affluent, white female adolescent, but males can 
also suffer from greater body dissatisfaction as well as problematic eating behaviors.3  
Additionally, the LGBTQIA+ community have shown a higher prevalence than their straight 
counterparts.3  Caucasians are the largest ethnic group affected by ED, but Mexican-American, 
African Americans, and Asians have been shown to be at risk as well.3  African American women 
have been shown to be at equal risk as their Caucasian counterparts, specifically for bulimia 
nervosa.3  As the second deadliest mental illness behind opiate addiction, one person dies every 
62 minutes from an ED.10  When the initial onset occurs during adolescence, it can result in up 
to a 25-year reduction in lifespan as well as impaired quality of life.11  The most prevalent ED is 
other specified feeding or eating disorder (OSFED), followed by binge eating disorder (BED), 
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bulimia nervosa (BN), and anorexia nervosa (AN).9  As the majority of research has focused on 
AN, BN, and BED, we will further detail prevalence by category.   
Feeding & Eating Disorder Types 
 
The American Psychiatric Association has outlined and defined diagnostic criteria for eight main 
ED in the Diagnostic and Statistical Manual of Mental disorders (DSM-V).  As we review the 
diagnostic criteria for each category, it is important to note that individuals should be carefully 
evaluated for an eating disorder regardless of other criteria if they are unable to maintain or 
attain a healthy weight, height, body composition or sexual maturation for gender or age.3   
 
AN is characterized by the restriction of energy intake resulting in significantly low body weight, 
intense fear of weight gain or the persistent behavior that interferes with weight gain despite 
low body weight, and a disturbance in body image, or persistent lack of recognition of the 
seriousness of their current low body weight.12  There are two other subtypes of AN, atypical 
and binge-purge AN.  Atypical AN is similar to the standard AN, but patients are not significantly 
underweight.13  Roughly between 42.1%-56.2% of those with AN will meet at least one criteria 
for another DSM-5 disorder.14  The most common being anxiety and major depressive 
disorders.14  Substance abuse is also present at a rate between 13%-27%.14  It is estimated that 
males represent between 10-25% of those patients diagnosed with anorexia nervosa and are at 
a higher risk of dying than their female counterparts partly due to a lack of education around 
diagnosing eating disorders and a lack of awareness of eating disorders in the male 
population.15  Anorexia has one of the highest mortality rates of all ED with an approximate 
mortality rate of 20%.12  More recent evidence supports that those suffering from AN will still 
meet full diagnostic criteria more than two decades after onset of AN.2  Less than half of those 
with AN will completely recover.16  Around 30% will show improvement while 25% maintain a 
chronic course.16 
 
BN is detailed as recurrent episodes of binge eating and inappropriate compensatory behaviors 
to prevent weight gain with a frequency of at least once per week for three months.12  Those 
that suffer from BN often express self-evaluation that is unduly influenced by body shape and 
weight.  In this context, binge eating is described as eating an excessive amount of food in a 
discrete period of time along with a sense of lack of control.12  Compensatory behaviors may 
include use of laxatives, diuretics, vomiting, fasting, or excessive exercise.  Of particular note, 
BN occurs in the absence of AN.12  The lifetime prevalence of BN is estimated between 1.7-2.9% 
with peak incidence between 16-20 years of age in females.14  Although studies vary, the male 
lifetime prevalence is estimated to be between 0.13% and 1.34%.17  Although BN is more 
prevalent than AN, it is generally diagnosed at a later stage.3  This can partly be attributed to 
the tendency for those with BN to be at weight or overweight as well as poor health screening 
practices across disciplines.3  The prognosis for BN is slightly better than those with AN.16  
Around 50% will recover, while 30% will maintain disordered behaviors.16 
 
Newly added to the DSM-V is binge eating disorder (BED).  Similar to BN, BED consists of 
recurrent episodes of binge eating that occur at least once per week for three months, however 
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without the additional compensatory behaviors as is the case in BN.12  It is associated with 
symptoms such as eating more rapidly, feeling uncomfortably full, eating while not feeling 
hungry, and eating alone due to embarrassment and/or feelings of self-disgust.12  Patients often 
note marked distress around binge eating.  It occurs in the absence of AN and BN.12  The 
lifetime prevalence of BED in males and females is around 2.0% and 3.5%, respectively.5,17  As 
this has been newly added to the DSM-V, there is limited research available. 
 
Other recently added ED to the DSM-V include, pica, rumination, avoidant/restrictive food 
intake disorder (ARFID), other specified feeding or eating disorder (OSFED), and unspecified 
feeding or eating disorder (UFED).  A diagnosis of pica is classified as eating of one or more 
nonnutritive, nonfood substances on a persistent basis over a period of at least 1 month that is 
inappropriate to the developmental level of the individual.18  It occurs in the absence to any 
cultural or socially normative practices.18  Furthermore, if the eating behavior coincides with 
another mental disorder such as autism, a separate diagnosis of pica should only occur if severe 
enough to warrant additional clinical attention.18  Rumination features repeated regurgitation 
of food over a period of at least one month and the regurgitated food may be re-chewed, re-
swallowed or spit out.18  Similar to pica, if the behavior coincides with another mental disorder, 
diagnosis of rumination should only be considered if it is severe enough to warrant the 
additional diagnosis.18  It can only occur in the absence of BN, AN, BED, and ARFID.18  The 
current prevalence data on both rumination and pica is inconclusive, however an increased 
prevalence in those with intellectual disabilities is noted.18  
 
ARFID is noted when there is an eating or feeding disturbance with the persistent failure to 
meet nutritional needs associated with significant weight loss or growth failure, significant 
nutritional deficiency, dependency on enteral/supplemental feeding or marked with 
interference with psychosocial functioning.12  These symptoms are not explained by lack of 
food availability, other medical illnesses, or cultural practices and occurs in the absence of AN, 
BN, or body image disturbances.12  The OSFED category is for those eating disorders causing 
significant distress, but not meeting the criteria for the other diagnostic categories.12  OSFED 
has a lifetime prevalence estimated around 7.6%.1  Night eating syndrome, purging disorder, 
subthreshold binge eating disorder, low frequency/limited duration BN, and atypical AN would 
be classified under this category.12  The last category, UFED covers eating disorders where there 
is presentation of clinically significant symptoms, but they do not meet the full criteria for other 
ED.12  Additionally, subclinical eating disorder behaviors such as binge eating, purging, laxative 
abuse, and fasting for weight loss is nearly as common among males as to females.15 
Risk Factors 
 
There are several risk factors associated with the development of ED that cover a variety of 
genetic, physiological, environmental, psychological or temperamental factors.  From a genetic 
or physiological standpoint, those that have a history of gastrointestinal problems, brain 
abnormalities, childhood obesity, and early pubertal maturation may be more susceptible.3,18  
From a familial side, those with a first-line relative with a history of an eating disorder, bipolar 
and depressive disorders, as well as a history of alcohol or substance abuse have an increased 
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risk.  Additionally, those that have experienced family anxiety, are part of cultures or 
occupations that value thinness, or have had a history of neglect, physical, emotional, or sexual 
abuse are more predisposed.18  From a temperamental view, there are some key personality 
characteristics.  Those with BN are often characterized with increased impulsivity and risk-
taking behavior, while patients diagnosed with AN often have a difficult time expressing 
negative feelings, exhibit low self-esteem, and show some degree of constraint.3  Comorbid 
anxiety disorders, autism, obsessive-compulsive disorder, attention-deficit/hyperactivity 
disorder, or those that display obsessional or perfectionistic traits are associated with the 
development of ED.18  Lastly, those with a history of dieting, obesity, and/or an increased focus 
on weight or body image either from themselves or from family members may be more 
vulnerable.3 
Screening & Diagnosis 
 
Being able to correctly diagnose ED is paramount in the treatment and prognosis of a patient 
with an eating disorder.  Early intervention is associated with a better prognosis, so it is 
essential that health care professionals be familiar with the early signs and symptoms of ED.16  
Unfortunately, many cases of ED are missed by health practitioners.  In fact only half of all cases 
of AN and one-third of BN cases are ever detected by the healthcare system.14  According to 
Murray only 26% of those with ED will receive any consultation for symptoms let alone engage 
in supported treatments.2  Approximately 20% of females and 13% of males will go into 
treatment.2  Since the initial onset of ED is skewed towards adolescence and young adulthood, 
it suggests that this is a prime time for prevention efforts, while the higher prevalence later in 
life highlights the importance of identification and treatment for long term prognosis.9   
 
ED are multi-factorial and as such require a multi-disciplinary team approach.  At a minimum 
treatment teams include a physician, dietitian, and psychologist or therapist.  Patients may 
initially present for treatment at any one of these team members and may not even realize they 
have an eating disorder.16  Thus understanding how to screen and what to watch out for with 
regards to signs and symptoms is imperative among all practitioners.  On a basic behavioral 
level, there are some symptoms that are associated with ED and should highlight to look further 
into identifying and diagnosing.  If a patient exhibits a strong tendency for extreme physical 
activity, frequent meal skipping, restrictive eating patterns, thinness as a valued goal, 
unrealistic goals, poor coping skills related to life events, and/or withdrawal from friends then a 
deeper investigation should be warranted.3  Children that have obsessive-compulsive traits 
such as perfectionism, having to follow rules, and concern about mistakes are much more likely 
to develop an ED than those that do not, so practitioners should be watchful.19  There are a 
number of screening tools that can be utilized to assist in the detection and diagnosis of ED.  
The most widely known is the SCOFF questionnaire which only consists of 5 questions.12 1) Do 
you make yourself sick because you feel uncomfortably full?12  2) Do you worry that you have 
lost control over how much you have eat?12  3) Have you recently lost more than one stone 
(6.35 kg) in a 3-month period?  4) Do you believe yourself to be fat when others say you are 
thin?12 5) Would you say that food dominates your life?12  If the client answers 2 or more 
questions with a yes, then a diagnosis of AN or BN may be likely.12  Bright Futures and the 
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Guidelines for Adolescent Preventative Services (GAPS) are also useful evidenced-based 
screening forms.3  The Bright Futures screening tool utilizes a variety of questions including how 
do you feel about the way you look, how do you feel about your weight, are you trying to 
change your weight, and do you ever fast, vomit, or take laxatives or diet pills to control your 
weight.3  The GAPS guidelines recommends screening adolescents annually for ED and to 
inquire about body image and dieting patterns.3  However, according to the National Institute 
for Health and Clinical Excellence (NICE) guidelines, the most effective screening tool probably 
remains the practitioner thinking about the possibility of an eating disorder.12,20   
Warning Signs & Symptomology 
 
In addition to screening tools, there are a number of warning signs or symptoms that can aid in 
the detection and identification of ED.  A detailed client history is critical in the assessment 
process and in determining the level of care.  Significant symptoms can be divided into five 
main categories: cardiovascular, gynecological, gastrointestinal, psychological, and other.14  
Common symptoms of someone with AN include hypotension with a systolic blood pressure 
below 99 mm HG and/or a diastolic blood pressure below 50 and bradycardia with a heart rate 
below 60 beats per minute.3,14  It is important to note that patients, parents, and even 
physicians may link a slow heart rate as a sign of fitness, when it could be a sign of 
decompensation as is the case in malnutrition.3  Additionally, around 30-50% of patients with 
AN have mitral valve prolapse.  With severe malnutrition, cardiac muscle diminishes, but the 
size of the valve does not, leading to prolapse.3,14  Another possible complication in those with 
AN who also purge via self-induced vomiting is the development of pneumomediastinum, a 
condition where air leaks into the mediastinum.14  It is hypothesized that malnutrition causes 
thinning of the alveolar walls and connective tissue, which can predispose patients to 
pneumomediastinum when intrathoracic pressure increases such as is the case during 
vomiting.14  Patients have also shown congestive heart failure, dysrhythmias, orthostatic 
hypotension, pericardial effusion, syncope, and electrocardiographic abnormalities.3  In 
addition, patients with BN who abuse ipecac, which contains alkaloid emetine, are at risk for 
cardiomyopathy, which can result in heart failure and ventricular arrhythmias when taken in 
excess.14 
 
From a gastrointestinal perspective, delayed gastric and colonic emptying, abdominal pain and 
distention are all common complaints in those with AN and BN.3,14  Those with AN are higher at 
risk for this and are often diagnosed with gastroparesis, gastric distention, gastroesophageal 
reflux, constipation, and superior mesenteric artery syndrome.3,14  BN patients who self-induce 
vomiting often complain of painful swallowing, hoarseness, dysphagia, and heartburn 
secondary to gastroesophageal reflux.14  Patients who abuse laxatives may complain of diarrhea 
and abdominal cramping.14  With regards to constipation, it is important to not treat with 
stimulant laxatives such as Senna-Gen and bisacodyl due to the potential for long-term abuse, 
which puts the patient at risk for developing colonic nerve cell damage causing cathartic colon 
syndrome.14  Patients who have a history of abusing stimulant based laxatives may develop 
rebound constipation.14  Other common gastrointestinal issues include acute pancreatitis, 
Barrett’s esophagus, bloody diarrhea, esophagitis, esophageal rupture, gallstones, and 
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perforation or rupture of the stomach.  Barret’s esophagus occurs from chronic 
gastroesophageal reflux that affects the lining of the esophagus causing it to thicken and 
become red.14  Mallory-Weiss tears and parotid hypertrophy are primarily seen in those with 
BN.  Mallory-Weiss tears or lower esophageal tears that typically occur due to violent 
vomiting.14  Parotid hypertrophy is the chronic enlargement of the parotid glands in those who 
purge via vomiting as seen in BN and atypical AN binge-purge type.14,21  The tale-tale signs of 
enlarged parotid glands is swelling of the cheeks.14  Additionally acid reflux from self-induced 
vomiting and damage to the esophageal sphincters can affect the pharynx and larynx and can 
lead to the development of laryngopharyngeal reflux.22  The regurgitated acidic contents can 
come into contact with the vocal cords and surrounding areas resulting in hoarseness, 
dysphagia, chronic  cough, and repeated sore throats.22   
 
The most prominent gynecological symptoms among females is irregular menstrual cycles, 
amenorrhea, or delayed pubertal development in adolescents.  In female patients with AN 
development of hypothalamic amenorrhea syndrome can occur resulting from variable 
reduction in pulsatile hypothalamic GnRH gonadostat signaling to the pituitary gland resulting 
in failure of ovulation.23  As a result of this gonadotropin failure, individuals with AN have 
decreased levels of the sex hormones, estradiol, estrone, progesterone, and testosterone.23  
Menstrual irregularities are also common in BN although usually less severe and prevalent than 
in cases of AN.23  Typically, this functional hypogonadotropic, hypogonadism-induced 
amenorrhea reflects a temporary and reversible disturbance in function.23  According to Golden 
et al., menses can be expected to resume at a weight that exceeds 90-93% of ideal body 
weight.24  However, other studies have demonstrated more variable weights than predicted 
weights.23  Additionally, there is some evidence that weight loss may not be the only factor 
causing amenorrhea.  Amenorrhea can precede significant weight loss in about one-quarter of 
women and can persist even after weight restoration, while other women may resume 
menstruation despite a low body weight.23  It is thought that adaptive hormonal responses to 
sociocultural-psychic stress, excessive exercise and chronic nutritional energy deficiency along 
with reduced thyroid and leptin levels may also contribute.23  From a medical standpoint, 
treatment efforts should focus on the overall treatment of the ED as there is little inherent 
value in administering female sex hormones (i.e. birth control) as withdrawal bleeding can 
promote a false sense of well-being and minimize the need for therapy.23  Men with AN display 
a few abnormalities of reproductive hormones including low testosterone, LH, and FSH which 
may lead to poor semen quality, reproductive suppression, decreased sperm motility, and an 
increase in immature sperm number.23,25   
 
It is important to note that pregnancy in women with an ED is still possible.  At least 1 in 20 
women experience some form of an eating disorder in pregnancy with the highest risk for those 
with a history of an eating disorder.26  A 2013 study found that 7.5% of women receiving their 
first routine ultrasound scan during pregnancy met the criteria for an eating disorder.27,28  
Another study showed that 28% of subjects displayed disordered eating symptoms and 
psychological and behavioral traits associated with ED during pregnancy.29  Unfortunately, 
93.3% of the women in this study were not identified by their medical practitioners.29  This is 
especially important as it is associated with a greater incidence of complications for mother and 
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child.  Those with BN have 2x the risk for hyperemesis gravidarum, increased weight gain, and 
miscarriage.26,30-32  Mothers with BED are at risk for increased weight gain and pre-term 
delivery.  AN has been associated with low weight gain during pregnancy33.26,30,31  All mothers 
are at higher risk for gestational diabetes, hypertension, and pre-eclampsia.26,30,31  The child on 
the other hand is at risk for being large or small for gestational age, smaller head 
circumference, stillbirth, low birth weight, low APGAR scores, breach, and cleft lip and/or 
palate.26,31  Even 2-6 months post-partum, mother and child are at continued risk.  The mother 
is more likely to stop breastfeeding, increase eating disorder behaviors including quick weight 
loss, and are 5X more likely to develop mood disorders such as depression.31  The baby is more 
at risk for decreased child feeding, low mother-child attachment, and roughly 17% will have 
failure to thrive within the 1st year.31 
 
Psychological co-morbidities and dual diagnosis are prominent in ED.  The presence of 
comorbidity is a strong indicator of poorer long-term outcomes and is associated with more 
severe symptoms.34    In a study of more than 2400 hospital patients with an eating disorder, 
researchers found that more than 97% had one or more co-occurring conditions.  The study 
further found that 94% had co-occurring mood disorders such as major depression, 56% with 
anxiety disorders, 20% had obsessive-compulsive disorder, 22% with post-traumatic stress 
disorder (PTSD), and 22% with alcohol or substance abuse disorder.19  In fact, two-thirds of 
people with AN had signs of an anxiety disorder before the onset of their eating disorder.19  
Further supporting the high prevalence of comorbid psychiatric disorders, a national 
representative survey found that 95% of respondents with BN, 79% with BED, and 56% with AN 
met the criteria for at least one other psychiatric disorder.5  Among those BN respondents, they 
also noted that 64% met the criteria for three or more co-occurring psychiatric disorders.5   
 
As one of the top 3 comorbid psychiatric disorders, PTSD can occur when a person is exposed to 
a traumatic event such as death, threatened death, actual or threatened serious injury or 
sexual violence.18  This exposure can result from the direct experience with the traumatic 
event, witnessing the event in-person, learning of a traumatic event that occurred to a close 
family member or friend, or first-hand, repeated experiences or extreme exposure to adverse 
details of the traumatic event.18  Symptoms of PTSD can be grouped into four main categories 
including intrusion symptoms, avoidance, negative alterations in mood, and alterations in 
arousal and reactivity.18  Some of these symptoms may include flashbacks, nightmares, 
irritability, angry outbursts, exaggerated startle, problems concentrating, insomnia, being 
overly watchful, numbing, forgetting, partial amnesia, negative beliefs around oneself, others, 
or the world, and self-blame.18  Evidence suggests that ED patients may be sensitive or 
vulnerable to stress and its consequences.  Two national representative studies have shown 
that individuals with BN, BED, or binge eating have higher rates of PTSD symptoms than those 
without ED.5,35  The lifetime prevalence of PTSD among BN groups range between 38-44%.5,35  
Additionally, women who were victims of assault were 1.86X more likely to develop BN than if 
they hadn’t been victimized.35,36  In another study looking at PTSD and AN, the researchers 
found that 13.7% of participants met the criteria for PTSD.37  When they delved further into the 
results, they found that AN purging subtype had higher odds of PTSD than standard AN.37  
Another study found that 48% of females and 68% of males with AN, up to 41% of females and 
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24% of males with BN, and up to 35% of females and 16% of males with BED have experienced 
some form of sexual violence.36  Unresolved trauma and/or PTSD may be an important factor in 
the maintenance of eating disorder symptoms.  Similar to the way substance abuse may be 
used to self-medicate, binge eating and/or purging may also help reduce the hyperarousal or 
anxiety symptoms associated with trauma as well as help numb or avoid traumatic 
experiences.38  These behaviors are reinforcing, making it difficult to break the cycle.38  As a 
result, individuals with ED complicated by trauma and PTSD need treatment for both conditions 
utilizing a trauma-informed, integrated approach.38  Of note, the best approach to address both 
PTSD and ED remains debated, but work so far primarily focusses on cognitive behavioral 
therapy with integrated treatment for the eating disorder.38 
 
Additionally, personality disorders occur commonly in individuals with ED.  In a meta-analysis 
examining the prevalence of personality disorders and ED, they found that avoidant personality 
disorder, dependent personality disorder, and obsessive-compulsive personality disorder (OCD) 
were commonly associated in both AN and BN, while borderline personality disorder, which is 
marked by impulsivity and instability is common among BED.39  Additionally comorbid 
substance use disorders (SUD) are common with roughly 1 in 5 individuals developing a SUD at 
some point in their lifetime and roughly 1 in 10 meet current criteria for a SUD.40  The lifetime 
prevalence of comorbid SUD among adults with AN, BN, BED, and subthreshold BED is 
estimated between 23-37%.40  In a meta-analysis, researchers found that among the highest 
prevalence of comorbid SUD was tobacco (36.1 ± 23.1%), caffeine (23.8 ± 12.5%), alcohol 
(20.6 ± 16.0%), or any other illicit drug (19.8 ± 19.6%), cannabis (14.5 ± 16.0%), and cocaine 
(13.7 ± 23.4%).40  Lifetime SUD comorbidity is higher among females, Caucasians, and 
individuals with BN and binge-purge behaviors.40  It is estimated that roughly 20% of individuals 
being treated for a SUD report binge eating.41  Of men with BED, 40.4% report having struggled 
with a SUD.42  ED and SUD share many common risk factors including brain chemistry, family 
history, low-self-esteem, anxiety, and depression.43  They also share similar characteristics such 
as compulsive behavior, social isolation, and risk for suicide.43  Successful treatment of 
comorbid psychiatric diagnoses and SUD in patients with ED can be challenging when the 
patient is malnourished as starvation can have a significant impact on mood and cognition and 
some psychiatric symptoms may improve with weight restoration.3 
 
Beyond the gastrointestinal, cardiovascular, reproductive, and psychological issues associated 
with ED, there is a vast array of other signs or symptoms.  Other affected areas include 
dermatologic, endocrine, skeletal, hematologic, neurologic and fluid and electrolyte balances.  
Hematologic effects of ED include bone marrow suppression, mild anemia, leukopenia, 
thrombocytopenia, impaired cell-mediated immunity, and low sedimentation rate.3  
Neurologically speaking patients might have cortical atrophy, myopathy, peripheral 
neuropathy, and even seizures.3  From a dermatological standpoint, patients often present with 
brittle nails, alopecia, lanugo on the arms and sides of their face, and dry skin and hair.3,14  
Acrocyanosis, alopecia, hypercarotenemia, and knuckle calluses also known as Russel’s sign 
have been noted.3  Russel’s sign is indicative of self-induced vomiting in BN patients.3  
Hypercortisolism, growth retardation or short stature, low T3 syndrome and partial diabetes 
insipidus or an inability to concentrate urine has been noted in adolescents with ED.3 
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The skeletal ramifications are detrimental and include osteoporosis, osteopenia, and fractures.3  
As a disease characterized by low bone mass and deterioration of the microarchitectural 
structure of the bone, osteoporosis results in bone fragility and nontraumatic fractures due to 
low bone mass.23  Osteoporosis is present in almost 40% of patients with AN, while osteopenia 
is present in 92%.  This is particularly of concern as peak bone mass generally occurs between 
the ages of 17 and 22, which often coincides with the onset of AN.23  Once amenorrhea is 
present, the estrogen-progesterone deficiency plays a role in hindering bone development and 
promoting bone resorption.23  In addition to the hypothalamic hypogonadal state addressed 
above, excess hydrocortisone secretion, low insulin-like growth factor 1 (IGF-1), and low 
androgen levels are often present.14  Low levels of IGF-1 reduce the levels of osteocalcin and 
can cause abnormalities in osteoblasts.23  The elevated cortisol levels are also inversely related 
to levels of osteocalcin.23  All of these factors together, are likely to promote the rapid and 
aggressive bone loss in individuals.23  Other signs of ED include poor dentition in BN and 
complaints of fatigue, peripheral edema, and bloating.3,14   
 
Fluid and electrolyte imbalances are a major concern for those with ED.  Laboratory results such 
as blood count and electrolytes should be reviewed.  In more severe cases of AN, anemia, 
leukopenia, hypoglycemia, and hypophosphatemia have been noted.14  The more concerning 
electrolyte abnormalities occur in the early stages of refeeding in patients with AN.14  Refeeding 
syndrome is the clinical complications that can occur as the result of fluid and electrolyte shifts 
during aggressive nutritional rehabilitation of malnourished patients and can potentially be 
fatal when not detected or treated early in nutritional rehabilitation.44  When reintroducing 
glucose into the diet it stimulates insulin secretion to help promote uptake of glucose as well as 
potassium, magnesium, and phosphorus into the cells.14  Phosphorus is then used for protein 
and glycogen synthesis and is quickly depleted.14  This process leads to a state of 
hypophosphatemia that causes adenosine triphosphate depletion which impairs muscle 
contraction in the heart and diaphragm resulting in cardiopulmonary failure.14  Additionally, the 
increased uptake of magnesium and potassium into cells further contribute to cardiac 
arrhythmias and muscle weakness.14  In BN patients, lab results can point to metabolic alkalosis, 
hypochloremia, and hypokalemia.14  The frequency of hypokalemia and hypochloremia in 
patients who purge through vomiting has been shown to be related to the frequency of daily 
purging.14  In one study, more than 40% of patients who purged twice a day or more became 
hypokalemic.14,45  Hypokalemia puts them at risk for atrial and ventricular arrhythmias.  Both 
vomiting and diuretics produce a contraction alkalosis secondary to dehydration and 
subsequent activation of the renin-angiotensin system.14  Pseudo-Bartter syndrome may 
develop due to purging and creating a chronic state of dehydration and hypokalemia.14  When 
the renin-angiotensin system is stimulated, it causes an increased amount of aldosterone to be 
secreted, which then attempts to restore intravascular volume via increasing sodium 
absorption in the distal convoluted tubule, but at the expense of potassium and hydrogen 
excretion.  This is important to note as aggressive fluid administration can lead to rapid and 
severe edema.14  Other known fluid and electrolyte imbalance complications in ED patients 
include decreased glomerular filtration rate, elevated blood urea nitrogen (BUN), 
hyponatremia, and ketonuria.3,14   
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Suicidality & Eating Disorders 
 
There are many factors that are associated with an increased risk of suicidality or self-injurious 
behaviors among individuals with ED.  Comorbid psychiatric diagnoses, illness severity, 
substance abuse, excessive exercise, child abuse, and alexithymia all have been associated with 
an increased risk.46  Additionally, among age groups, adolescents show a strong relationship 
between suicidal behavior and completed suicides.46  Among the different subtypes, the overall 
mortality risk including by suicide appears to be significantly higher among individuals with AN 
when compared to BN and BED.  Within the subtypes of AN, 7.4% of AN-restricting types 
reported at least one suicide attempt whereas 20-30% of other subtypes of AN reported at 
least one suicide attempt.46  However, suicide attempts seem to be more prevalent in BN than 
in AN.46  Women who suffer from BN and who were alcohol-dependent report a higher rate of 
suicide attempts than those not alcohol-dependent.43 
Neurochemistry 
 
Several studies have researched how neurotransmitters and hormones are involved in 
disturbances across the eating disorder spectrum.  In particular, research has focused on the 
role of monoamine systems such as dopamine and serotonin.47  Many AN patients have high 
levels of anxiety, obsessive-compulsive behaviors, and harm avoidance.47  In acute AN, patients 
have displayed significantly lower levels of serotonin metabolites, reduced 3H-imipramine 
binding, and blunted prolactin responses to drugs with serotonin activity, which suggests 
reduced serotonin activity.47  Serotonin is known to influence impulse control, obsession, 
mood, and appetite.47  Additionally, AN patients may have higher levels of serotonin prior to 
the onset of symptoms leading to a dysphoric state, so significant dieting or starvation may 
actually make them feel better by reducing serotonin activity in the brain.47  It is believed that 
starvation in AN leads to less consumption of the essential amino acid tryptophan, which acts 
as a precursor to serotonin.47  With tryptophan depletion, the brain responds by increasing the 
number of serotonin receptors in an effort to utilize the remining serotonin more efficiently.47  
All of this leads to a cycle where in order to feel better patients need to reduce food 
consumption to reduce tryptophan.47  When they start to eat more food with tryptophan, 
serotonin levels rise sharply causing anxiety and emotional chaos making it extremely difficult 
to recover.47  Chronic stress may also play a role as it is may increase serotonin levels creating 
yet another reason to diet to help alleviate the dysphoric state.47  Different from AN, BN sees 
serotonin levels drop even during short periods of fasting leading to mood irritability and binge 
eating episodes.47  Similar to AN, there is some evidence that suggests that disruptions in the 
serotonergic system may exist prior to the onset of BN.47  In contrast, the tryptophan depletion 
in BN lowers mood and causes the urge to binge.47  Further supporting reduced serotonin 
production, studies have shown that the activation of the serotonin receptor helps reduce 
binge eating.47  When SSRI medication is introduced, patients often experience a reduction to 
binge.47 
 
The neurotransmitter, dopamine, plays a role in movement, attention, learning, reward 
processing, and may be related to novelty seeking.48  In AN, patients have reduced 
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concentrations of cerebral spinal fluid homovanillic acid (HVA), the major metabolite of DA.48  
BN patients, however, appear to have normal HVA levels.48  However, binge frequency may 
decrease HVA levels.48  It is hypothesized that the low DA levels in AN patients could be related 
to the altered reward response to food, the low motivation to approach food, and the 
difficulties with behavioral change during treatment.48  This could result in impaired cognitive 
flexibility.48  The different balance between DA and serotonin activity in AN and BN may 
contribute to the differences in overt expression between patients.48  Further research is 
needed to define the role of DA in BN.   
 
Along with disruptions in neurotransmitters, many neuropeptides are altered including 
neuropeptide Y (NPY), peptide tyrosine (PYY), and cholecystokinin (CCK).48  NPY exerts an 
appetite stimulant signal over the hypothalamic-pituitary-adrenocortical axis increasing the 
adrenocorticotropic hormone, cortisol, and prolactin release, which is known to be involved in 
appetite regulation.49  In as study by Galusca et. al, patients with AN were unable to upregulate 
NPY to adapt to their energy demand when exposed to chronic undernutrition.50  High levels of 
NPY are associated with high food intake.49  The dysregulation of these peptides may account 
for the erratic consummatory patterns in AN and BN.48  Luckily, these alterations seem to 
normalize with recovery.  CCK is a peptide hormone of the gastrointestinal system that 
promotes satiety, but interestingly is also related to anxiety, panic, and hallucinations.  In a 
study by Cuntz et al., they found that AN patients had similar plasma levels of CCK when 
compared to healthy individuals both pre- and post-prandially suggesting hormonal 
adaptation.51 Although, results have been inconsistent in prior studies.49  PYY, a gut peptide, is 
secreted in the ileum an colon and plays a role in loss of appetite.  Batterham & Bloom 
conducted a study comparing serum levels of PYY hormone between patients with BN/BED and 
AN.52  Unsurprisingly, serum levels of PYY hormone were decreased in BN/BD comparative to 
AN.52 
 
Orexins are orexigenic neural hormones that are expressed and secreted in the lateral 
hypothalamus as well as in peripheral tissues such as the kidney, pancreas, ilium, and colon.49  
Orexins interact with leptin by regulating neural orexigenic pathways and indirectly modulating 
the activity of orexigenic neurons in the lateral hypothalamus.49  In AN patients, orexins seem 
to be upregulated.49  Although further research is necessary, it is postulated that this up-
regulation might result from an adaptive mechanism to increase food intake in undernourished 
conditions or that this chronic increase could reinforce dopamine induced anxiety further 
increasing the aversion to eat.49 
 
Ghrelin, also known as the hunger hormone, is a peptide hormone expressed in the stomach 
with lesser expression in the pancreas, gallbladder, colon, and brain.49,53  In the brain it exerts a 
paracrine effect by activating orexigenic NPY neurons and inhibiting anorexigenic neurons 
increasing appetite.49  When the stomach is empty, ghrelin increases gastric secretion and 
gastrointestinal motility.49  Ghrelin binds to its receptor, the ghrelin/growth hormone 
secretagogue receptor, and triggers the synthesis of NPY leading to an increase in appetite.49  
Additionally, the effects of ghrelin also involve the reward system activation via dopamine 
pathways.49  Interestingly, studies have actually reported elevated ghrelin levels in AN 
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patients.49  The hormone, leptin, on the other hand promotes satiety.49  It is involved in the 
regulation of energy balance both in the long and short term.49  Leptin stimulates anorexigenic 
neurons expressing proopiomelanocortin and corticotropin release factor while inhibiting NPY 
neurons.49  AN and BN patients exhibit low levels of plasma leptin in cerebrospinal fluid 
pointing to the potential importance of leptin homeostasis in ED.49 
 
Several interesting findings have been noted in brain imaging studies of patients with ED.  MRI 
studies have found reduced gray and white matter in symptomatic AN and BN patients.48  
Additionally, it has been reported that in the prefrontal cortex there is a lower ratio of N-acetyl 
aspartate to choline, a lower ratio of glutamate to glutamine, and lower myo-Inositol 
concentrations in AN patients.48  This is of note as N-acetyl-aspartate is the precursor of 
neuronal peptides involved in brain myelin synthesis and choline is required for 
neurotransmitter activity.48  PET studies have found resting state hypo-perfusion in the frontal, 
parietal, and temporal brain regions in those with AN.48  These findings reveal the neuronal 
membrane damage and reduced hemodynamic brain activity secondary to malnutrition.48 
Metabolism 
 
Eating disorders lead to metabolic changes throughout the disease state.  Loss of lean body 
mass has been associated with significant reductions in resting metabolic rate, low body 
temperature, and depletion of the brain, heart, and other organ tissues.54  Undereating, fasting, 
starvation and malnutrition all lower metabolic needs as the body tries to compensate for these 
life-threatening consequences.54  Additionally, in this state when caloric intake is inadequate, 
exercise can further compound and actually contribute to lowering RMR to conserve energy 
rather than increasing one’s metabolism.54  Metabolic studies have shown resting metabolic 
rates (RMR) between 50-70% of normal RMR in both AN and BN.54,55  In this “famine” state the 
body lowers its metabolic rate so that it can store as many calories as fat so that it will be ready 
and able to survive the next time “famine” occurs.54  In the famine state, your body first 
depletes its stores of carbohydrates.  Since the brain’s favorite energy source is carbohydrates 
or glucose, the body then switches to obtain glucose from alternative mechanisms or 
gluconeogenesis when stores are depleted.54  During gluconeogenesis the body starts breaking 
down protein and fat and converting some of the by-products to glucose, even at the expense 
of breaking down other body tissues to obtain energy.54   
 
When a patient starts the refeeding process, RMR can actually increase through the process of 
weight restoration making it difficult for some to gain weight.54  In fact, RMR has been shown to 
increase disproportionately in comparison to body weight or lean body mass.54  Krahn et al., 
found that patients with AN exhibited a rise of 25-30% above predicted values of a variety of 
predictive equations.54  In a study by Wymelbeke et al., researchers measured resting energy 
expenditures in 87 AN patients and found that with a goal rate of weight gain of 1/3 lb. per day, 
would on average require around 75 kcal per kilogram of body weight.56  It is theorized that this 
hypermetabolism is related to the high calorie costs of growing lean body mass tissue, protein 
synthesis, muscle mass, bone formation, heart rate, heat dissipation, and restoring fat stores.54  
This is particularly important when determining energy requirements in ED patients.54  Over 
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time, improved caloric rate and weight gain can normalize metabolic rate.54 
Determining Levels of Care (LOC) 
 
Understanding the physiological, psychiatric, and nutritional implications of ED has important 
clinical implications as they can affect how treatment is approached, levels of care, prognosis, 
and mortality.  Primary treatment of ED is multi-disciplinary and determination of levels of care 
will be dependent on how ill or affected the individual presents.3  The continuum of care for ED 
includes outpatient care, intensive outpatient programs (IOP), partial hospital programs (PHP), 
residential programs, and inpatient hospitalization.34  Determining the level of care is often not 
a straight forward process and practitioners should consider existing practice guidelines from 
reputable organizations while also taking into account individual differences with regards to 
predicting treatment response.34 
 
The American Psychiatric Association (APA) defines several factors to be considered when 
determining levels of care including age of patient, symptom severity, course of illness, medical 
status, weight as a percentage of healthy body weight, suicidality, patient motivation, 
psychosocial or family support, regional availability of specialized inpatient or outpatient 
programs and associated psychiatric comorbidity (See Appendix 1).12,34,57  According to the APA, 
patients should first try to receive treatment at facilities within a close distance to home if at all 
possible, but if that is not feasible admission to a residential or inpatient facility that provides 
housing should be seeked.34  Other factors needing to be considered is the amount of structure 
needed for weight restoration, ability to control compulsive exercising, purging behaviors, and 
environmental stressors.  Other factors that may signal a higher level of care such as inpatient, 
residential or PHP include the patient being a significant risk of suicide or severe self-harm.34  
The range and extent of comorbid psychopathology can also pose challenges to treatment.  For 
comorbid disorders such as SUD, PTSD or mood disorders, it is important to consider whether 
to address both disorders simultaneously and, if not, which disorder is primary to treat first.34  
However, sequential treatment may lead to relapse in one disorder as the other disorder 
improves.34   
 
At higher levels of care where treatment is more structured, providers frequently make critical 
decisions regarding patient care such as imposed treatment, enforced feeding, and 
determination of capacity when patients are unwilling or unable to consent to treatment.34  
These environments are critical to restoring health, but it can affect motivation and 
autonomy.34  Regardless of treatment setting, patient autonomy can include respecting patient 
choice, refraining from controlling treatment with external consequences, and helping patients 
become engaged in treatment.34  Autonomy has been shown to be a significant predictor of 
behavior change in eating disorder patients.34  Treatment is more effective when it is 
collaborative and relies on patient autonomy.34 
 
Inpatient Hospitalization 
 
Inpatient hospitalization is the highest level of care and is designed for patients presenting 
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with medical instability.34  All three organizations, APA, NICE, and the Royal Australian and 
New Zealand College of Psychiatrists (RANZCP) provide a clear outline for determining medical 
stability and recommend that patients not meeting outlined requirements should be 
considered for admission to an inpatient level of care.34  In adults, medical instability is 
specified to include a heart rate <40 bpm, blood pressure <90/60 mmHg, fasting glucose <60 
mg/dL, potassium <3 mEq/L, electrolyte imbalance, temperature <97.0 F, dehydration, poorly 
controlled diabetes, and indication of organ compromise or a BMI of <14 kg/m2.34  For 
children and adolescents, the APA and RANZCP indicates medical instability by a heart rate 
near 40 bpm, orthostatic blood pressure changes (<20 bpm increase or <10-20 mmHg drop, 
blood pressure of <80/50 mmHg, hypokalemia, hypophosphatemia or hypomagnesmia.34  
Additionally, inpatient treatment may be necessary if the patient’s symptoms such as 
vomiting, laxative use, or compulsive exercise are uncontrolled and require 24-hour 
supervision.34  Inpatient hospitalization has subspecialty medical consultation readily 
available, supervised meals, and one-on-one monitoring if necessary.34  Traditionally, these 
programs have 24/7 skilled nursing care, daily physician visits, subspecialist physician visits as 
needed, and at a minimum 1 weekly dietitian visits to oversee the patient’s nutritional 
rehabilitation.23  A psychotherapist may be part of the team at this level, but provides 
supportive sessions rather than in-depth psychotherapy.23  Often the patient is too weak or 
cognitively impaired by malnutrition to engage in this type of therapy.23  The overall goal in 
inpatient hospitalization focuses on medical stabilization, beginning nutritional rehabilitation, 
effectuating weight gain to 65-70% of IBW and then referral to an outpatient team or another 
specialized facility among the continuum of care for continued nutritional and weight 
restoration.23 
 
Residential Treatment 
 
The next level down from inpatient hospitalization are residential treatment programs.34  
These programs house patients full-time in a non-hospital-based treatment setting where 
patients receive meal support and multidisciplinary treatment including individual and group 
therapy.34  Residential treatment typically has 24/7 nursing supervision and a minimum of 2 
weekly physician visits.  Similar to inpatient, clients usually have twice weekly individual 
psychotherapy visits, 1 weekly family therapy visit, and 1 weekly dietitian visit.  Other 
disciplines such as occupational therapy or educators may be involved depending on the 
facility.23  The average length of stay in a residential treatment is approximately 83 days, 
however it can vary based on a variety of factors including insurance and patient 
motivation.34 
 
Partial Hospitalization Program 
 
The next step down the continuum is PHP.  PHP settings typically offer treatment from 6 to 11 
hours a day and between 3 to 7 days a week in more of an outpatient setting.23,34  In this 
setting, patients spend nights and sometimes weekends at their home allowing them to 
maintain social relationships as well as utilize skills they have learned throughout treatment 
out in the “real-world”.34  During treatment patients receive daily meals, snacks, and group 
P a g e  20 | 53 
 
therapy as well as regular meetings with a therapist, dietitian, and psychiatrist.34  According 
to Mehler et al., typical treatment includes a minimum of 1 physician and/or nursing care 
visit, twice weekly individual therapy session, 1 weekly family therapy visit and 1 weekly 
dietitian session.23  After initial assessment, medical follow-up is provided as needed 
including blood draws to monitor phosphorus levels.23  Depending on the facility and patient 
other disciplines may be included such as activity and occupational therapists and educators 
for child and adolescent programs.23  As patient’s ED behavior symptoms lessen or stop, the 
program will often adjust or reduce the days and hours expected of the patient in the 
program.23 
 
Intensive Outpatient Program 
 
IOP programs offer outpatient treatment for approximately 3-4 hours a day and between 3 to 
5 days per week.34  Similar to PHP, IOP typically includes meal support, group therapy, 
individual therapy, dietary sessions, and medication management.34  At this level, physician 
care and family therapy is typically as needed whereas weekly individual therapy and dietetic 
sessions are usual practice.23 
 
Outpatient Treatment 
 
Outpatient treatment teams can vary widely.  At this level, the primary responsibility is on the 
client and/or family to manage and locate treatment providers.  Typically, initial medical and 
psychiatric medication evaluations are recommended during the first outpatient visit with 
follow-up visits with physicians and psychiatrists as needed.14  Psychotherapy sessions often 
are provided once to twice per week with family or couple therapy added if indicated.23  
Depending on the severity, weekly to monthly visits with a dietitian for nutritional counseling 
is necessary.23  Weight monitoring is often provided by the registered dietitian or by the 
medical physician.23  With treatment providers often not under the same location, one of the 
most challenging parts of the multi-disciplinary treatment team is maintaining 
communication and providing coordinated care.23  Of note as medical and psychiatric 
symptoms are typically minimal at this level of treatment, team communication is often 
coordinated by the psychotherapist.23  RANZCP and NICE differ slightly on guidelines for 
transition to higher levels of care in that they state that transfer to higher levels of care is 
recommended only when a patient demonstrates non-responsiveness to outpatient care.34  For 
patients not needing immediate hospitalization, treatment should be individualized and initially 
take place in an outpatient setting if possible.12,34   
 
Overall, patients may move through the various LOC based on severity of symptoms, medical 
status, motivation, treatment history, and financial limitations.34  This movement can be 
bidirectional based on patient needs.34  It is important to note that stepping between LOC can 
be destabilizing for patients.34  It is preferable to continue with the same treatment team 
while moving through the differing levels.34  Transition planning must be done carefully and 
communication between programs and disciplines should be clear and ongoing throughout 
treatment.34   
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The Multidisciplinary Team 
 
As ED are multi-factorial and have physical, psychological and nutritional implications the 
treatment team often includes at a minimum a physician, psychologist, and dietitian, although 
many other disciplines may be involved.  Each member of the treatment team possesses unique 
skills and responsibilities with respect to patient care.  There can be considerable overlap in 
what each member of treatment team does to help promote recovery from ED.16  Patients may 
initially present for treatment to any of the three primary team members and the severity of 
eating disorder dictates the LOC and the speed of referrals to other members of the 
multidisciplinary team.16   
 
Physician 
 
Physicians are responsible for the assessment and initial diagnosis, treatment of any medical 
complications, assessment of weight and nutritional status, referral to appropriate health 
professionals, education of the patient and their family, prescribing medication, and providing 
ongoing medical monitoring.12,16  The initial assessment should specifically include height, 
weight, the patient's perceived ideal body weight (IBW), body mass index (BMI) or BMI 
percentile for age, heart rate and blood pressure with postural measurements, temperature, 
assessment of breathing, edema and peripheral circulation, skin color, hydration status, the 
examination of head, neck, skin, hair, and nails, and muscle power.12 
 
Laboratory tests should include a full blood count, urea, electrolytes, creatinine, AST, ALT, 
alkaline phosphatase, blood glucose, B12, folate, iron workup, calcium, magnesium, phosphate, 
thyroid function tests, follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, 
and prolactin.12  Other tests may include urinalysis, electrocardiography, x-rays, and bone 
densitometry.12  X-rays are useful for the identification of bone age where delayed growth may 
be of concern.  Bone densitometry is recommended after 9-12 months of disease in the case of 
amenorrhea.12  
 
Medical history should include questions around eating behavior such as a 24-hour recall of diet 
intake, the number of meals per day, eliminated food groups, and binging or purging 
behaviors.16  A psychological history should be obtained and include questions about life 
stresses, relationship issues, and problems at work or school.  Since the registered dietitian and 
psychologist will also collect some of this information, this allows for cross-referencing of data 
between disciplines to determine accuracy and content at team meetings.16  Additionally, 
family medical history of obesity, ED, and mental illness should be covered.16  The physician 
should pay particular attention to medications, such as diet pills, laxatives, oral contraceptives, 
and nonsteroidal anti-inflammatory drugs as they may indicate prior amenorrhea, purging 
behaviors, and history of overuse injuries resulting from exercise activity.16 
 
Some patients may be in denial of having an eating disorder or the severity of the disease.  To 
help overcome this denial, the physician may visually present the laboratory and radiology 
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results when communicating abnormalities.14  Although rare, forced hospitalization may be 
indicated in a medically unstable patient who refuses treatment.  Involuntary care should be 
considered if the patient has a psychiatric disorder, this disorder presents a substantial 
possibility of death by direct or indirect action of the patient, and the patient does not 
recognize the need for treatment despite the life-threatening illness.14  It is recommended that 
a consultation with a psychiatrist is obtained to assess the patient's competence as legalities 
are complex.3  If the patient is medically stable, then it is still recommended to consult social 
work and psychiatry to provide resources and referrals for outpatient treatment.3 
 
Psychotherapist 
 
The psychotherapist helps monitor mental health issues and process underlying issues.16  
Psychotherapy can be delivered by psychiatrists, clinical psychologists, social workers, and 
master’s level counselors or psychotherapists.23  The initial meeting is critical for the mental 
health provider to determine how to proceed with treating the client including what 
psychotherapy approaches, modalities, and the length and frequency of sessions.23  The initial 
assessment should include an intake interview covering the presenting problem, psychosocial 
history, current mental status, diagnosis, and treatment plan.16   
 
The primary role of the therapist is to build a trusting interpersonal relationship with the 
patient.16  They should provide the client with a review of how the treatment team works 
together, alleviate any fears around trust, and determine treatment goals that are patient-
directed.16  Discussion around the nature of the eating disorder, the stigma associated and 
confronting any moral or self-blame issues are important.16  Although destructive, eating 
disorder behaviors often serve valuable functions and may act as an effective distraction from 
stressors.3  These behaviors may be a patient’s attempt at distress tolerance and regulation.3  
The psychotherapist plays an important role in helping the client reframe change and develop 
alternatives for coping with stressors.3  Additionally, the psychotherapist is responsible for 
providing the patient factual information, providing structure, but also the flexibility to develop 
their self-identity.3  They need to create a safe atmosphere to let the client just be.16 
 
Registered Dietitian 
 
Registered dietitians (RD) assess the nutritional status of the patient including food attitudes,  
eating patterns and behaviors.  Specifically, they provide and implement a treatment plan, 
monitor nutritional status and changes in eating patterns and behaviors.16  Nutritional 
assessment should include a food frequency interview along with typical daily intake.  When 
asking the client about food-frequency of a particular food, the dietitian is also focused on 
inquiring information around attitudes about food rather than the accuracy of intake of that 
food.16  Asking about a typical good day versus a bad day may give the dietitian valuable insight 
into the patient’s nutritional knowledge.16  Since patients with ED often are not forthright about 
volunteering information, dietitians need to ask direct questions around past and current 
eating patterns, compensatory behaviors such as the use of diet pills, laxatives, diuretics, 
vomiting, ipecac syrup, enemas, food restriction, fasting, and excessive exercise.16  Additionally, 
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obtaining a weight history is important.  The dietitian should work with the client by having 
them discuss when the patient last remembers not being concerned about food, weight, or 
body and then moving chronologically forward.16  Note that although the physician is also 
responsible for reviewing the physical status of the patient, the dietitian should also review 
those same points as patients may not have disclosed the same signs and symptoms to other 
providers.16  This is also an important time to assess what support system the patient has in 
place.  If this is the first point of contact in treatment, the dietitian will need to make referrals 
to other disciplinary team members.3  Additionally, if the patient is working closely with a 
physician, the dietitian may need to weigh the importance of obtaining an additional weight 
measurement during their nutrition appointment.16  Sometimes patients experience a great 
deal of anxiety around being weighed and not obtaining may help reduce anxiety connected to 
it and the nutrition session, by allowing them to focus on nutrition and not weight.16  They then 
communicate and coordinate their findings and treatment regimen to the other members of 
the treatment team.16   
 
During treatment, one of the first priorities is to develop trust between themselves and the 
patient, so that the patient can feel comfortable.16  This helps the dietitian dispel nutritional 
myths and hopefully help the client comply with future plans.16  Registered dietitians are 
responsible for challenging the patient in a safe and structured environment.16  Depending on 
the eating disorder stage, the dietitian will either work on decreasing behaviors or improving 
nutritional intake first.16  This nutritional rehabilitation stage may involve weight restoration, 
achieving energy balance, compensatory behavior withdrawal, and discovering hunger 
awareness, if possible.16  Throughout the treatment process, the RD is responsible for providing 
nutritional education around weight regulation, energy balance, effects of starvation, dieting 
myths, consequences of purging, fluid retention, and emotional connections to food 
behaviors.16  The dietitian should inquire about bloating, gastric emptying, fluid retention, 
fullness, diarrhea, and constipation as well as monitoring for refeeding syndrome.16  
Additionally, they will be monitoring signs and symptoms as related to nutritional 
rehabilitation, changes in patient’s energy level, social environment, mood swings, fear of 
weight gain, food obsession or restriction, cognitive function, symptom change, preoccupation 
with food, body, or calories, and awareness of hunger and fullness throughout treatment.16  
The majority of patients will benefit from vitamin and mineral supplementation.  More specifics 
on supplementation will be addressed below. 
 
Other Coordinated Staff & Specialists 
 
Beyond the traditional treatment team, there are a variety of other specialties that may be part 
of the treatment process.  Nurses working in the field may function in a variety of capacities 
including case managers, clinic nurses or coordinators, specialty coordinators, primary care 
clinicians or discharge planners.3 
 
Psychiatrists are typically responsible for medication management of psychiatric conditions.23  
It is recommended that psychiatrists are brought in early in the treatment process for 
evaluation and determination of the complexity of medications as well as the level of 
P a g e  24 | 53 
 
treatment.23  Depending on the psychiatrist's background they may also deliver psychotherapy 
in which they would be responsible for determining the frequency of sessions.23    Other 
disciplines such as family practice physicians and pediatricians may fill the role of psychiatrist 
depending on location and individual circumstances.23  Conversely, psychiatrists are informed 
about the medical management of ED patients and may assume that role, except for ED 
patients with the most severe form of illness.58  There currently is not strong evidence for 
psychiatric medications for ED, but better evidence for treating the comorbid psychiatric 
diagnoses.23  Other team members may include social workers, activities therapists, school 
teachers, and coaches.3  Activity therapy may include art therapy, equine therapy, yoga among 
others. 
 
Family Members 
 
The Academy for Eating Disorders states that families should be involved routinely in the 
treatment of young people with ED.6  How this is structured is going to vary by individual and 
family.6  Research points to the significant and essential role that parents may play in the 
treatment of ED in children and adolescents.  They act as key informants in the assessment of 
children and adolescents, especially since minimization or denial of symptoms is common.59  
Therapies, such as family-based therapy (discussed below), assign parents with a pivotal role in 
their child's recovery as well as provide parents with the support they need.59  The involvement 
of parents in the treatment process has been linked to a reduction in symptom severity and 
treatment attrition rates.59  At the same time, it is important to remember that family members 
caring for patients with ED often experience distress, anxiety, and diminished quality of life and 
as such it is key to keep that in mind as reducing caregiver strains may be important for 
improving outcomes.60 
Treatment Approaches 
 
There are a variety of common evidenced-based psychotherapy treatments for ED including 
cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), dialectical behavioral therapy 
(DBT), acceptance and commitment therapy (ACT), family-based therapy (FBT), and narrative 
therapy.23   
 
Cognitive Behavioral Therapy 
 
CBT is a psychotherapeutic approach to solve problems concerning dysfunctional behaviors, 
emotions, and cognitions through a goal-oriented, systematic procedure.61  It helps clients to 
analyze and test their existing patterns of thinking, emotional reactions, and behaviors through 
an assessment of current difficulties and then attempt to try out new approaches, monitoring 
those, and evaluating its effects.62  Research has pointed to the effectiveness of CBT in 
preventing relapse after weight restoration in adults with AN.63  Additionally, CBT is considered 
the most effective treatment for BN and BED, although treatment should be individualized and 
other psychotherapy treatments may be utilized.64,65  Several studies have shown that CBT has 
helped reduce the number of binge eating episodes as well as ceasing binge eating overall.66-68  
For dietary restriction, the course of CBT treatment is deliberately sequential.  For example, a 
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practitioner might first target developing a regular, more normal pattern of eating such as 3 
meals and 2 or 3 snacks.69  Then start to incorporate those “bad” or forbidden foods into the 
patients’ meal patterns.69  This is meant to help empower them and prove that normal eating 
won’t lead to loss of control.69  Treatment is designed for a slow and gradual increase in the 
overall amount of food consumed and thus caloric intake.69 
 
Interpersonal Therapy 
 
IPT is considered a time-limited (around 12-15 sessions), affect-, life event, and present-focused 
psychotherapy that emphasizes interpersonal relationships in the context of symptoms.  
Interpersonal problems are common in patients and may predate the onset of ED, which is one 
of the reasons IPT is thought to be beneficial in the treatment of ED.  In the setting of IPT, the 
therapist and patient work together to define the central interpersonal problem which may fall 
into one or more categories related to lack of intimacy and interpersonal deficits, interpersonal 
role conflicts, role transitions, major life changes, complicated grief, and life goals that may be 
interfering with interpersonal functioning.  In a multi-center study comparing CBT with IPT in 
BN patients, researchers found that CBT was superior at the end of the treatment with regards 
to normalizing eating attitudes and behaviors, however, in the long-term follow-up, there were 
no differences in results.70,71  In another study, researchers compared IPT and CBT in BED 
patients and found that recovery was similar for both CBT and IBT at the end of treatment and 
at the one-year follow-up.71,72  For patients with BN in which CBT has not seemed to be 
effective, the APA guidelines recommend IPT.64 
 
Dialectical Behavioral Therapy 
 
DBT works on the premise that maladaptive and impulsive behaviors function as a way to 
regulate unwanted emotions and focuses on developing adaptive skillful behaviors to help 
improve effective self-regulation.73  It is believed eating disorder patients often present with 
issues related to emotional under control such as in BED and BN while others may present with 
emotional overcontrol (AN).  With a wide range of behaviors such as binging/purging and food 
restriction, there is a growing interest in applying DBT as a way to develop adaptive skillful 
behaviors in place of those maladaptive behaviors.74  There are three primary DBT models for 
eating disorders.  The Stanford model proposes that binging and/or purging occur as a way to 
regulate painful affect specifically around emotional deficits found in patients with BN and 
BED.74  The radically-open DBT (RO-DBT) theorizes that temperamental threat sensitivity 
interacts with feedback from the environment that emphasizes self-control and minimizes 
mistakes.  This results in the inability of the individual to feel safe.  Patients with AN restrictive 
type are associated with heightened threat sensitivity, low reward sensitivity, loneliness, and 
inhibited emotional recognition.  As such, RO-DBT is based on openness, flexibility, and 
connectedness and as such teaches skills that target these issues of overcontrol that are 
thought to underlie their problematic behaviors, emotions, and cognitions.74  The third model, 
multi-diagnostic complex ED DBT (MED-DBT), was created to address multi-diagnostic, highly 
complex individuals with ED that require higher levels of care.74  This model combines CBT with 
DBT to manage multiple high-risk behaviors (i.e. suicide) in the context of emotional 
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dysregulation and therapy interfering behaviors.74  This model focuses on patient responsibility 
and flexibility in defining and achieving treatment goals.74  Overall, DBT is effective for the 
treatment of BED and initially effective with BN.74  The evidence does point to a particularly 
good fit with complex presentations of ED and comorbid disorders.74  However, although 
research has generally produced positive results, the extent does vary.  As a general rule, it is 
recommended that DBT be considered when CBT has not been effective or emotional 
regulation is hindering treatment effectiveness in those with BED and BN.74 
 
Acceptance & Commitment Therapy 
 
ACT works towards training individuals to actively and openly contact their current experiences 
fully present without defense and either change or remain in the behavior as it serves the 
person's chosen values.75  The purpose or goal of ACT is psychological flexibility leading to 
valued living.75  It is comprised of six components including cognitive diffusion, experiential 
acceptance, transcendent self-awareness, valued living, and committed action.75  ACT teaches 
patients to obtain psychological distance from distressing internal experiences through 
clarifying overarching personal values, creating goals that help patients live a more fulfilling and 
meaningful life, and increase their willingness to experience negative internal experiences in 
service of valued behavior.76  ACT is thought to be effective, because, at the core, ED have a 
devastating impact on valued living.75  Along those lines, the purpose of treating ED is to 
increase contact with the client’s values.75  ACT targets the broad behavior shift not in the sense 
of reducing behaviors, but by changing the dominant functions of behavioral repertoire and 
shifting life towards things that the client cares about.75  It is important to note that ACT is not 
currently regarded as an evidence-based treatment for ED, however, some studies have 
suggested that it leads to symptom improvement in patients with AN.77  Additionally, in the few 
studies on ACT in eating disorder patients, the effectiveness of treatment does not outperform 
other evidenced-based treatments such as CBT.77  
 
Family-Based Therapy 
 
Considered the gold standard intervention for adolescents with ED, FBT integrates techniques 
from a variety of psychotherapy approaches including systemic, strategic, narrative, and 
structural family therapy.78  The theory highlights the importance of incorporating patients’ 
interpersonal relationships into treatment approaches.78  There are three phases to FBT.  In 
phase 1, parents are assigned the responsibility of correcting the adolescents eating behaviors 
and low weight.59,78  In the second phase, once behaviors have been reduced, control over food 
consumption is transferred back to the adolescent.59,78  Once normal body weight is achieved 
and eating behaviors are normalized, the third phase begins focusing on more general issues of 
adolescent development such as creating a healthy adolescent-parental relationship, the 
adolescent's identity, and autonomy.59,78  A key aspect of FBT is to separate the ED from the 
patient to enable the parents to take action against the illness rather than their child78  
Although FBT is individualized to the client and family, generally phase 1 includes a minimum of 
weekly therapy sessions that last around 3-4 months, phase 2 then reduces sessions to every 
second or third week, and phase 3 transitions to sessions every third week or monthly 
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intervals.78  There has been particularly strong evidence for the effectiveness of FBT in the 
treatment of AN in adolescents.63  However, as each patient, family, and illness are unique, FBT 
may not be effective in all cases.  NICE recommends CBT when the treatment is ineffective or 
contraindicated.78 
 
Exposure Therapy 
 
Exposure therapy operates under the principle that stepwise exposure to the item promoting 
fear via introducing stimuli attempt to break the avoidance pattern, thereby allowing the 
patient to learn by experience that the feared consequences do not occur.79  There are four 
common forms of exposure therapy: exposure with response prevention for purging (ERP-P), 
exposure with response prevention for binging (ERP-B), exposure-response prevention for AN 
(AN-ERP), and body image exposure.79  ERP-P focuses on the prevention of binging or purging in 
a patient with BN or AN binge/purge.79  Since eating elicits a fear of weight gain and purging is 
often used to help cope with the associated anxiety, the purging behavior reinforces the 
removal of fear of weight gain.79  In ERP-P the client is gradually exposed to fear food cues and 
prevents the purging after consumption.79  The idea is that this method helps the client’s self-
efficacy and bolsters their ability to cope with stressors.79  Limitations of ERP-P include that it 
doesn’t take into account any cues that might precede binging and doesn’t emphasize binge 
eating as a maintaining factor in disordered eating.79  Additionally, ERP-P can be logistically 
complicated and time consuming.79   
 
ERP-B, also known as cue exposure, hypothesizes that if a conditioned stimulus predicts binging 
and elicits a physiological response such as craving, then repeated and/or prolonged exposure 
to the stimulus in absence of binging will result in less or complete removal of the craving.79  
For a patient with BED, professionals may expose the patient to binge foods via touch, smell, 
and small tastes while preventing the binge.79  Studies have shown ERP-B to produce positive 
results in terms of reduction of symptoms for clients who had not improved with CBT or 
pharmacological treatments, thus making ERP-B a good second-line treatment for those 
individuals.79  In a large RCT, researchers combined CBT sequentially with ERP-P, ERP-B, or a 
relaxation condition and found that at a 5-year follow-up both ERP groups showed greater 
improvements in BN symptoms than the combined CBT and relaxation treatment.79  In AN-
EXRP, patients with AN use graded food exposure to help reduce avoidance and facilitate 
habituation to anxiety around anticipation and ingestion of the “fear” food.79  The aim is to 
increase food choice flexibility and caloric consumption leading to an improved ability to 
restore and maintain weight and prevent relapse.79  Although a few limited preliminary studies 
on AN-ERP have shown positive results, many had very small sample sizes that confounded the 
results.79  Body image exposure has been used to reduce body dissatisfaction, body checking, 
and avoidance in patients with ED.79  This process often incorporates other modalities such as 
CBT for body image disturbance and cognitive dissonance-based mirror exposure.79  This 
exposure therapy often uses mirrors or videos to encourage individuals to look at each part of 
their body systematically for an extended period of time.79  This may occur while wearing tight-
fitting clothing with additional exposure homework assignments.79  Although research is 
limited, there is preliminary evidence in the short-term that clients experience improvement in 
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a low mood, self-esteem, body image, body checking, and weight or shape concerns.79  Further 
supporting the effectiveness of body image work, Murray et al. suggest that increased 
psychological flexibility around body image is associated with reduced symptomology severity, 
greater quality of life, and improved mental well-being.2  Overall, there is limited research on 
exposure therapy outside of inpatient or residential settings and this limits the ability of the 
research to decipher if the improved result is due to the food exposure therapy or other 
treatments.79  Larger, more robust studies are needed to evaluate the treatment in these 
patients. 
 
Narrative Therapy 
 
Narrative therapy explores factors that have contributed to the meanings that the patient has 
constructed about their life experiences and identifies the knowledge held by the patient 
concerning the influence of the eating disorder in their life as well as the factors that support or 
undermine that influence.80  At the same time, it allows the patient to reflect on ways of 
resisting or challenging the eating disorder and uses that as a foundation for further behavioral 
change.80  It operates under the premise that the client holds insider knowledge about living 
with the eating disorder that other professionals do not possess.80  It is a collaborative process 
between the client and the therapist, where the therapist is not seen as the “expert”.80  A major 
part of narrative therapy is the process of externalization.  It challenges the internalizing or 
individual pathological language and argues that ED arise out of cultural, familial, and social 
relationships and experiences.80  This process of externalization creates a space or separation 
between the patient and the eating disorder by engaging in conversations that position the self 
in relationship to thoughts, feelings, experiences, and actions.80  This is key as many patients 
with ED view themselves as the problem rather than adopting an identity separate from the 
eating disorder leading to guilt and self-blame.80   
 
Group Therapy 
 
Group therapy incorporating various modalities such as CBT and IPT may be utilized throughout 
the treatment process. Group psychotherapies include peer interpersonal feedback, social 
learning, emotional expression, and group cohesion that may be particularly useful in targeting 
interpersonal problems for some individuals.81 According to Grenon et al. found that participants 
who underwent group psychotherapy were 5.51 times more likely to abstain from binge eating 
and or purging than those not undergoing group psychotherapy.81  The APA practice guidelines 
for the treatment of patients with eating disorders and the APA Task Force on Evidenced-Based 
Practice both include group CBT and IPT as the two psychotherapies that have shown strong 
evidence for BN and BED.81 
 
Intuitive Eating 
 
Considered the founders of intuitive eating (IE), Evelyn Tribole and Elyse Resch, state that 
intuitive eating is the dynamic mind-body integration of instinct, emotion, and rational 
thought.82  As only you can be the expert of your own body, thoughts, feelings, and 
experiences, it relies on the personal process of honoring health by paying attention to what 
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our bodies tell us in order to meet our physical and emotional needs.82  Intuitive eating is 
guided by 10 principles: 1) reject diet mentality; 2) honor your hunger; 3) make peace with 
food; 4) challenge the food police; 5) respect your fullness; 6) discover the satisfaction factor; 7) 
honor your feelings without food; 8) respect your body; 9) exercise-feel the difference; and 10) 
honor your health.82,83  These principles were designed to help guide body attunement or the 
ability to hear and respond to physical sensations and by removing those obstacles standing in 
the way to body attunement.82  Overall, intuitive eating is about building a healthy relationship 
with food, body, and mind while focusing on self-care and body appreciation regardless of body 
size.82  The effectiveness of IE in the treatment of ED has shown some promising results.   
Research has found that IE has been associated with improved trust in one’s body being able to 
monitor food requirements and that it may lead to closer adherence to recommended caloric 
requirements.83  Although opinions vary, this may be important for those with AN as they 
present with restriction of energy intake relative to their requirements.83  In a 2-year pilot 
study, researchers found that patients with AN have the ability to learn to intuitively eat in a 
highly structured treatment setting in conjunction with other medical, nutritional, and 
psychological considerations.  Additionally, they found that IE was associated with reductions in 
symptomology, depression, anxiety, social conflict and improvements in body image and 
spiritual well-being.83  Similar reductions in symptomology and improvements in attitude have 
been found in experimental studies around IE and disordered eating such as binge eating.83-85  
Patients with BN often have difficulty recognizing and responding to satiety cues making IE a 
particularly important intervention.83  In a study of patients with BN, researchers found that 
patients were able to improve their ability to eat intuitively.83  IE was linked with decreases in 
binging episodes and increased feelings of self-control.83  However, research on the long-term 
efficacy is limited in the eating disorder population.   
 
Health at Every Size 
 
Health at Every Size is an interdisciplinary movement that focuses on health promotion through 
supporting health behaviors for all body sizes without using weight as a focus.86  It focuses on 
encouraging body acceptance rather than weight loss or weight maintenance, utilizing IE to 
focus on our internal cues, and actively moving in a way that feels good.86  Recently, HAES has 
gained momentum in the eating disorder community.  Currently, the Academy for Eating 
Disorders, Binge Eating Disorder Association, Eating Disorder Coalition, National Eating Disorder 
Association, and the International Association for Eating Disorder Professionals support the 
HAES approach as standard practice in the ED setting.86  Several evidence-based studies have 
shown that the HAES approach is associated with statistically and clinically relevant 
improvements in blood pressure, blood lipid levels, physical activity, eating disorder pathology, 
mood, self-esteem, and body image in overweight individuals and those that experience binge 
eating.84,87-89  As prospective studies have linked body dissatisfaction with binge eating and 
other eating disordered behaviors, it is believed that by learning to accept your body, cueing 
into your internal hunger and fullness cues, and reducing the focus on weight that it will lead to 
more normalized eating pattern among patients.86  However, there is a need for research on 
the effectiveness of HAES as it relates to the subtypes of eating disorders. 
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Pharmacology & Supplementation 
 
Pharmacology 
 
Many patients may benefit from medication so that they can more fully participate in 
treatment, although it is always important to individualize treatment.14  Antidepressants are 
the most frequently prescribed followed by antipsychotics in children and adolescents with 
AN.64  Pharmacological management is often utilized when comorbid psychiatric disorders such 
as depression, anxiety, and delusions.64  The use of atypical antipsychotics in patients revolves 
around the rationale that patients with ED can have irrational beliefs or delusions around body 
shape.64  Additionally, they can assist in managing anxiety and depressive symptoms also 
present in ED.64  In AN, atypical psychotics, such as olanzapine, risperidone, and quetiapine, are 
generally regarded as safe and acceptable, however evidence of enhanced weight gain in AN is 
limited.64  Olanzapine when compared against other antipsychotics was shown to promote 
more rapid weight gain and improved AN psychopathology including a reduction in depression, 
anxiety, obsessive-compulsive symptoms, and aggression.64  The APA suggests the utilization of 
atypical antipsychotics may be useful in individuals with severe or treatment-resistant 
symptoms.64 
 
Antidepressant medications have not been found overly effective in the treatment of AN.  It is 
believed that this is due to the depletion of central serotonin that occurs with weight loss as 
well as the inadequate intake of tryptophan, a precursor of serotonin.64  The symptoms of 
starvation may coincide with or mimic features of depression and these symptoms are often 
improved by improving nutritional status.64  However, selective serotonin reuptake inhibitors 
(SSRIs) may play a role in treating the comorbid depression and anxiety symptoms after weight 
restoration.64  Guidelines currently recommend a trial of SSRI antidepressants as an initial or 
alternative treatment in BN in conjunction with CBT.16  SSRIs, including citalopram, 
escitalopram, and sertraline, have demonstrated the strongest efficacy in reducing binge eating 
episodes and improvement in other clinical indicators in the BED population.64  These are 
indicated as a first-line pharmacotherapy by the World Federation of Societies of Biological 
Psychiatry for BED.64  Tricyclic antidepressants (TCAs) are commonly prescribed medication for 
adolescents with AN to help with comorbid depression, obsessive-compulsive symptoms, self-
harm.64  However, there are some serious concerns in this population related to the potential 
for TCAs to cause arrhythmias at a low body weight.64  In the cases of AN, there currently is no 
clear evidence on the addition of pharmacotherapy to psychotherapy, except in the cases of 
comorbid psychiatric conditions.64  The TCAs, imipramine, amitriptyline, and desipramine, have 
displayed some efficacy in BN with a reduction in binge frequency, depression, and anxiety in 
RCT, however, they are not tolerated well.64  Due to their adverse effects and overdose toxicity, 
they are not recommended as a first-line treatment for adults with BN and is discouraged in 
children and adults.64  Fluoxetine is recommended as a first-line medication in BN as it has 
shown to prevent BN psychopathology, depression, and help to prevent relapse in large sample 
randomized control trials.64 Although research is limited on TCAs in BED, there is some promise 
in the reduction of binging, however, they don't seem to promote weight loss, so they are not 
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recommended as a first-line treatment.64  Another class of antidepressants that have shown 
some promise in the reduction of BN symptoms are monoamine oxidase inhibitors or MAOIs.  
However there are significant side effects and some dietary restraints associated.64  When 
comparing TCAs, MAOIs, and SSRIs no one class outperformed in regard to efficacy and rarely 
lead to complete symptom remission and as such are inadequate as a monotherapy.64 
 
Among several anti-epileptic drugs tested in RCT, topiramate was the only drug that has 
exhibited good efficacy as it relates to the reduction of binge and purge episodes.64  However, it 
has several side effects such as sedation, dizziness, headache and paresthesia which limits its 
tolerability among patients.64  Among the BED population, the anti-epileptics, topiramate, and 
zonisamide have been proven to reduce binge frequency and weight loss, but similar to the BN 
population, their side effects lead to a high discontinuation rate limiting their clinical 
effectiveness.64  Research has also looked the effectiveness of utilizing the pancreatic lipase 
inhibitor, orlistat, in the BED population.64  The evidence showed an overall decrease in binging 
and improved weight loss with mild to moderate gastrointestinal issues.64  One dietary item to 
keep in mind is that Orlistat may affect the absorption of fat-soluble vitamins and negatively 
affect growth in adolescents.64 
 
Overall, the use of medication in the treatment of ED should be used as part of a multi-modal 
treatment plan incorporating in nutritional, medical and psychosocial interventions and not 
solely as a monotherapy.64  Studies on various medications have shown limited efficacy across 
ED.64  Clinicians should use psychological and behavioral multidisciplinary approaches as the 
front line treatment in ED with medication as an additive treatment for those where more 
support is necessary.  Close monitoring of medications is required and if deemed ineffective 
should be reviewed and adjusted as a priority.64 
 
Supplementation 
 
Food intake in eating disorder patients can be unpredictable and can lead to neurobiological 
dysfunction.  Studies have highlighted several nutrient deficiencies, including electrolytes, 
vitamins, and minerals that may play a role in this dysfunction.90  Ideally, a person should obtain 
adequate nutrients via a varied diet.  In an eating disorder patient, one may need to offer 
nutrient supplementation in addition to the diet as consumption may be an issue.   As always, 
close monitoring is recommended.  
 
Patients with ED typically do not have deficiencies in the essential fatty acids, however, deficits 
in long-chain polyunsaturated fatty acids, such as omega 3 or omega 6 have been 
demonstrated.90  Omega 3 fatty acids have demonstrated some control in inflammation and 
oxidative stress, so a deficiency in omega 3 fatty acids could be related to dysfunction.90  This 
inflammatory dysfunction and increased oxidative stress have been shown to be a marker of 
ED.49,90  As such, it is hypothesized that supplementation of polyunsaturated fatty acids may 
prevent neuronal damage and act as an anti-inflammatory agent.90  Several studies have shown 
the usefulness of omega 3 fatty acid supplementation with regards to significant improvement 
in symptoms.90-92   Although more research is needed in this area, most studies to recommend 
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treatment with omega 3 fatty acids.90 
 
Electrolyte abnormalities can be a common consequence of purging behaviors such as vomiting 
or abuse of laxatives.90  Excessive vomiting is known to cause hypokalemia and or 
hypochloremic alkalosis.90  Laxative abuse has been linked to hypomagnesemia and 
hypophosphatemia.90 Hypocalcemia is common in patients with ED.90  Often blood plasma 
levels of calcium are not accurately representative of calcium levels as the body tries to 
maintain homeostasis via calcium from the bone to compensate for deficits leading to poor 
bone density, which is a better indicator of long-term calcium deficits.90  For calcium deficiency, 
supplement with calcium carbonate up to a total of 1500 mg per day elemental calcium from 
food and supplement.93  As these electrolytes are critical, emergency supplementation is 
recommended based on individual needs.90   
   
The lack of nutrition in the diet often leads to abnormally low plasma iron levels.90  In addition, 
erythrocyte hemolysis can contribute to iron deficiency in patients who are heavy 
exercisers.90,93  Interestingly, amenorrhea may offer some protection from iron deficiency.90,93   
Replenishment of iron stores is a long-term process so supplementation and monitoring may be 
required even after food intake is normalized.90,93 
 
Results have been mixed with regards to vitamin A supplementation.90,93  Elevated serum levels 
of vitamin A have been attributed to inadequate intake of other nutrients that are required for 
vitamin A metabolism whereas decreased serum levels were associated with inadequate 
vitamin A intake.90,93  Vitamin A is common in many fruits and vegetables that ED patients tend 
to eat, however, if the diet is low in fats, absorption can be hindered.90,93  Inadequate zinc 
intake may also impair vitamin A absorption and metabolism.90,93  Based on existing literature, 
it would be premature to recommend supplementation beyond the recommended daily 
allowance (RDA).93 
 
Deficiency in several B vitamins is common mostly due to inadequate food intake although 
comorbid SUD in the form of alcohol may contribute to deficiency.90,93  Food restriction can 
lead to low thiamine (B1), riboflavin (B2), pyridoxine (B6), folic acid (B9), and cobalamin (B12).90,93  
Thiamin deficiency can cause varied neuropsychological symptoms including worsening of 
depression symptoms, a common comorbid condition.90  B6 deficiency may exacerbate ED 
because of its link to serotonin metabolism.90  Similar to B6, thiamin may also exacerbate 
psychiatric symptoms.90,93  We also know that deficiency in cobalamin or B12 can produce 
symptoms of anemia and long-term damage can lead to brain damage.90,93  Currently, no 
recommendation is available for supplementation of B1, B2, B6, and B9 beyond supplementation 
at the RDA.93  Most commonly, Vitamin B12 is often supplemented via an intramuscular injection 
of 1 mg of cyanocobalamin per month.93 
 
Vitamin C deficiency is rare in the ED population as it is available in a variety of fruits and 
vegetables.90,93  Bleeding gums or poor wound healing may point to a deficiency as can over-
exercise with poor dietary intake.93  If a deficiency is detected, supplementation above the RDA 
(up to 400 mg per day) is appropriate until urinary excretion indicates tissues are saturated.93 
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Vitamin D deficiency is likely in patients when there is limited dairy intake and/or have little to 
no exposure to sunlight.90,93  A study on AN patients found a strong link between vitamin D 
values and bone mineral density and as we know AN is associated with loss of bone mass.  
Currently, there is no consensus on supplement strategy in the ED population.93 
 
Studies on zinc deficiency in eating disorder patients have been variable.93  Zinc deficiency may 
be related to low dietary intake, especially in vegan patients or in the case of heavy exercise 
which can contribute to impaired zinc absorption.90,93  Initial laboratory tests taken after a 
period of weight loss may not accurately reflect the status as zinc is released from catabolized 
tissue.90,93  It can be particularly troublesome in eating disorder recovery as it can negatively 
affect an underweight patient from gaining weight, especially muscle mass.90,93  Additionally, as 
mentioned above, zinc deficiency can inhibit vitamin A metabolism leading to high serum 
carotenoid levels.93  It can also give a sense of depression and cause hypogeusia making it 
unappealing to eat.93  Zinc supplementation may be helpful even for patients that have slightly 
low serum zinc levels.93  In a double-blind trial, supplementation of 100 mg per day of zinc 
gluconate resulted in twice the rate of increase in BMI compared to the placebo.93  It is 
important to monitor food intake, because as preferences change and patients incorporate 
zinc-rich foods, supplementation may no longer be advised.93 
  
Tryptophan, an essential amino acid and precursor to serotonin, has become of interest in the 
treatment of ED.  Since tryptophan is an essential amino acid, one must obtain it through their 
diet.  When diet intake is inadequate a deficiency may occur leading to lower levels of 
serotonin.90  Studies have suggested that response to antidepressants can be hindered if there 
is a deficiency in tryptophan.90  Supplementation of tryptophan is not recommended as 
monotherapy but as an adjunctive treatment.90  Supplementation aims to normalize the 
neurobiological mechanisms involved in the disorder and also make the pharmacological 
treatment of serotonergic drugs more effective.90 
 
Along with tryptophan, some have started looking at the possibility of supplementing arginine, 
another essential amino acid that is often deficient when intake is low.90  Arginine has 
particular relevance in the synthesis of nitrous oxide, which plays a role in vasodilation.90  Since 
mortality of ED is sometimes related to cardiovascular issues, studies have focused on 
investigating the role of arginine in patients with ED.90  Currently, arginine supplementation is 
lacking scientific backing.90 
 
Other Medical  & Nutritional Protocols 
 
Long term goals for treatment revolve around normalized eating behaviors, nutritional 
adequacy, and medical stability.3  Patients tend to respond better to short term goals and will 
vary based on the level of treatment and individual.3  For instance, the first goal for a patient in 
an inpatient setting might be vital sign stabilization and to increase weight to >75% of their 
IBW.3  With regards to determining body weight goals, many methods are used.  In a survey 
spanning 100 treatment providers, a variety of approaches were used including consulting a 
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patients' growth curve history, utilizing BMI standards, relying on physiological markers such as 
the return of menses, consulting patients for their preferred goal weight, and making 
inferences based on behavioral symptoms.2  It is imperative that each member of the treatment 
team be on the same page with regards to goal weight.2  As patients work toward their goal 
weight, the typically acceptable weight gain in the outpatient setting for adolescents is 1 kg (2.2 
lbs.) a month.3  If there is a lack of progress in the outpatient setting, such as agreed to weight 
gain or continued purging, referral to a more specialized or higher level of care may be 
necessary.3 
 
Throughout the weight restoration and refeeding process, there are a wide variety of treatment 
effects to be watchful of.  First, as severe malnutrition can result in decreased cardiac muscle 
mass, the ability of the heart to contract is reduced.14  As a consequence, intravenous fluids 
should be done carefully as to not overload the weakened heart and precipitate pulmonary 
edema.14  Additionally, for those that have electrolyte imbalances as may be the case with 
purging, the first line of treatment should be to focus on the correction of dehydration.58  This is 
essential to decrease aldosterone and limit renal potassium and hydrogen losses.58  Note that in 
the cases of purging, completely turning of aldosterone may take a few weeks after cessation of 
purging.58  To combat the propensity toward edema, spironolactone, a potassium-sparing 
diuretic may be used for up to 1 to 2 weeks.58  To prevent refeeding syndrome, the current 
recommendations are to start the refeeding process slowly.58  Intake levels usually begin at 
levels around 600-1000 kcal per day and are increased by 300-400 kcal every three or four days, 
with the caveat that it should be individualized based on the rate of weight gain.58  The caloric 
requirements necessary for weight gain can vary between 1800-4500 kcal per day.58  There are 
a few general rules to follow: 1) The TEE should never exceed BEE, 2) caloric intake should 
rarely exceed 70-80 kcal per kilogram of body weight, 3) for a severely malnourished patient 
begin a diet at 20-25 kcal per kg, 4) protein intake should not exceed 1.5-1.7 grams per kilogram 
of body weight and is generally in the 1-1.5 gram range, 5) if TPN or enteral feedings are 
required, carbohydrate intake should not exceed 7 mg per kilogram per minute, and 6) weight 
gain should be in the 2-3 pounds per week. Liquid supplementation may need to be prescribed 
to achieve the caloric goal needed to achieve weight gain.58  Caloric intake must be modified 
throughout refeeding, because of changes in the REE.58  Checking for edema is important as it 
can be a sign of refeeding syndrome.58  In addition, in the early phases of refeeding, insulin 
secretion normally increases causing sodium retention by increasing kidney tubular sodium 
reabsorption.58  If this is noted, a low-sodium diet should be part of the nutritional plan.58  As 
always, frequent and close monitoring of a patient’s blood chemistry including at a minimum 
potassium, phosphorus, magnesium, sodium, and glucose is a must.58  It is recommended daily 
lab draws be obtained early on until they are more normalized.58  Other metabolic 
complications may include elevated liver enzymes, thiamin deficiency, and hypoglycemia.  
Slight elevations in AST and ALT, two liver enzymes, are typically noted in the first few weeks of 
refeeding followed by increases in alkaline phosphatase and bilirubin.58  There is little clinical 
significance usually and they typically resolve with a slowing of the rate of the refeeding 
process.58  If elevations are significant, the RDN may need to reduce carbohydrate-dextrose 
calories.58  Thiamin deficiency in the acute refeeding period is life-threatening as it may cause 
congestive heart failure or Wernicke's encephalopathy and must be monitored.58  Additionally, 
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atrophy of intestinal mucosa and pancreatic impairment may cause severe diarrhea.58  
Hypoglycemia may be an issue as the large glucose loads in more aggressive refeeding regimens 
may stimulate insulin release from the pancreas that the depleted hepatic glycogen reserves 
cannot offset.58  This is particularly important if the patient is on enteral feeds or TPN as abrupt 
cessation can cause dangerous hypoglycemia.58  Lastly, delayed stomach emptying, and 
prolonged colonic transit time is often noted in AN.58  A bowel regimen with a judicious amount 
of fiber and hydration may help with these symptoms.58  For those with a history of laxative 
abuse, rebound constipation may occur.  It is recommended to use a non-stimulant laxative 
such as polyethylene glycol and to abstain from fiber-based products as they may cause 
bloating.14   
Coordination & Communication 
 
Regardless of treatment setting, coordination, and communication of findings and treatment 
among disciplines is critical.  Comparing information ensures comprehensive and cohesive care.  
It is essential to communicate the patient's level of motivation and participation in treatment, 
treatment goals, and progress or ambivalence about them.16  Topics or general themes in 
psychotherapy and circumstances or events that could complicate progress may also be 
noted.16  From a dietitian's perspective, gaining information on a patient's psychological state 
may highlight the potential for introducing nutritional concepts or changes at the right time.16  
Furthermore, when a food behavior is connected to a particular emotion, the dietitian can 
encourage the client to process it with their psychologist.16  From a physician standpoint, 
communicating the patient’s medical status and stability, weight, lab data, medical risks, 
current ED behaviors, medication adjustments, effectiveness, and any pertinent side effects to 
members of the team lets the team know where they are from a medical stability standpoint.16   
 
If communication is not well coordinated and clear among all team members, it can lead to 
patient splitting.16  Splitting is the phenomenon when a patient forms an alliance with a 
member of the multi-disciplinary treatment team in opposition to the other members 
threatening the overall effectiveness of treatment.16  Differences in opinions or perspectives 
among disciplines are why the treatment approach is most effective.16  It is common for 
patients to make progress on physical variables that the physician might see, but also show 
little progress in psychological behaviors.16  Likewise, if a patient’s physical and nutritional 
condition deteriorates, it may derail any positive psychological changes.16 
Barriers to Treatment 
 
Medical Perspective 
 
Several barriers have been identified via qualitative studies.  Linville et al highlighted seven 
themes for practitioners avoiding eating disorder screening during appointments.94  
Respondents comprised of physicians, nurse practitioners, and psychologists, expressed 
reluctance due to lack of time, interdisciplinary role confusion, lack of treatment options, 
perceived helplessness of provider, provider discomfort, education, and difficulty of treating 
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ED.94  Seventy-eight percent of the respondents reported having ED patients in their practice, 
but they felt unsure how to properly screen and treat them.94  Highlighting the need for more 
education, one participant noted that they had one lecture on ED in their psychiatry rotation.  
Further supporting the need, a national survey of university medical and psychology programs 
found didactic teaching hours among medical programs ranged from 1.94 – 5.25 hours, while 
general psychiatry and child and adolescent psychiatry ranged between 4-4.05 hours.95  Early 
identification and diagnosis are affected by the competence of professionals in the eating 
disorder field and the earlier we identify the better for the prognosis.12  There is a desire for 
more specifics about understanding appropriate diagnostic screening tools, prevalence rates, 
risk factors, height and weight norms for athletes and non-athletes, and eating disorder referral 
sources.94  Additionally, clarification on the multi-disciplinary roles and boundaries is necessary.  
Role confusion between disciplines can result in back and forth referrals that can prevent or 
delay interventions.94  Researchers highlighted that medical providers often think that ED are a 
mental health issue and mental health professionals can tend to view ED as a medical issue.94  
There are also several myths around ED that participants felt affected providers' ability to 
screen and provide an intervention.  They include that ED are a mental issue and doctors are 
not part of the treatment team, ED are just a phase, individuals with ED have a personality 
disorder and doctors can't help anyway.94  One participant noted that they were trained to 
think that there was nothing they can do for eating disorder patients and to just refer them to 
mental health practitioners.94  Reasons noted for the difficulty of treating disorders were lack of 
patient motivation, family denial, patient discomfort, confusion with the treatment process, 
lack of referral sources, and frequent patient relapses and setbacks.94  All respondents of the 
Linville et al. study noted a need for medical training programs to offer better training, 
continued education, and consultative forums on eating disorder topics and in particular 
recommended hands-on training, a brief screening tool, and a collaborative team.94   
 
Another area affecting treatment is confusion around the role of the family in the treatment 
process in the child and adolescent population.  Marcon et al. found that while physicians 
responded with a fair degree of accuracy regarding assessment, their responses regarding 
knowledge of treatment were not in line with best practice guidelines.59  In particular, only 
10.5% of participants correctly endorsed the statement that it is the parents' responsibility to 
bring their child to recovery than the child.59  Additionally, 79.2% agreed that children with ED 
will never get better until they receive some sort of individual therapy.59  Researchers noted 
that physicians lacked knowledge around the nature of the involvement of parents and 
provided conflicting messages to families involved in FBT.59  This can be problematic when 
children and adolescents with ED are already not accepting of family involvement with meal 
support and the refeeding process.59  This further supports the need for evidence-based 
protocols, curriculum development, and training.  It also points to the need for some cross-
training as it relates to the importance of FBT, specific ways for parents to become involved and 
education around effective family-orientated treatment strategies.59 
 
Dietitian Perspective 
 
A representative survey of US dietitians working in the ED field indicated a need for expanded 
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education on ED and disordered eating for RDs in pediatrics and other practice areas.96  They 
noted educational gaps around the role of genetics in the development of ED, etiology, 
prevention, identification, and care for patients exhibiting distorted thoughts and maladaptive 
behaviors with food and body, and counseling processes.96,97  The RDs surveyed noted that 
their formal education usually only included a brief introduction to ED with little information 
about how to treat them.96  If treatment information was provided it was outside of their 
nutrition coursework and did not cover nutritional interventions.96  This lack of education 
spanned undergraduate, coordinated programs, dietetic internships, and graduate 
coursework.96  Additionally, they noted that greater experience in the field and education 
covering the psychological aspect of ED are needed across health professions including RDs 
counseling children and adolescents for weight management.96  It’s important to note that 
without training in nutrition-focused treatment modalities, the RDN may be less effective in 
changing eating behaviors, which may delay the initiation of more effective treatment with an 
ED specialist.96  There is a need for research on the comparative effectiveness of nutrition 
therapies.96  Other research gaps revolve around predictors of recovery and methods to 
facilitate early recognition and referral.98  A study by Whisenant and Smith found that the 
reasons dietitians who do not work with ED and cannot identify them was attributed to lack of 
education, training, or experience, lack of awareness of psychological issues, denial of the 
eating disorder by the patient, orientation to the medical model of therapy that focuses on 
structured diets, and dietitians themselves having ED.98  Moreover, psychological issues with 
patients and their families can present a major barrier to dietitians.98  Knowledge of counseling 
techniques for patients and their families can be beneficial when educating about food and 
weight behavior.98  The researchers also noted that universities and internship programs have a 
responsibility to ensure every dietitian is capable of properly screening for, identifying, and 
referring patients with ED to the appropriate specialists.98 
 
Patient Barriers 
 
Patients have reported that they are more likely to be blamed for their disorder and to be 
perceived as attention-seeking.99  Studies among university students and adult women have 
highlighted that seeking treatment may be considered a weakness and that the perception 
from others is that ED are not real illnesses.100,101 Also, patients report feelings of shame and 
embarrassment around their illness and treatment.102  Another area of concern is the reported 
lack of family support or lack of understanding from their support circle as some prefer to seek 
help from informal sources such as family and friends.103  Building this support system to 
encourage treatment may have a major impact on the treatment process. 
 
Studies have also mentioned that individuals with ED do not always consider or understand the 
severity of their illness, which can prevent them from seeking help.104  Some more practical 
barriers include the cost of treatment, transportation, and lack of time for treatment.101  Rural 
areas may lack the necessary resources for treatment leading to the need to travel to find 
specialized treatment providers.104  From more of an internal eating disorder belief system, 
patients report a fear of gaining weight, losing the positive aspects of their ED, and losing part 
of their identity.105  Perceived positive aspects may include mood regulation, control, and 
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comfort.105  For some patients, they perceive that their eating disorder is an integral part of 
their identity and that life without it is unimaginable.105  Their eating disorder provides a sense 
of structure and meaning.105  There is also a lack of knowledge around available resources.  In a 
study by Cachelin et al., they highlighted that participants did not understand where to go to 
treatment nor what type of treatment exists for treating their eating problems.101  There also is 
a sense of distrust of treatment professionals among various communities.  Becker et al. 
highlighted how social stereotypes can act as a barrier to care.  When compared to white 
participants, African Americans, Hispanic, and Native Americans were significantly less likely to 
receive a referral to care.100  Additionally, participants reported that clinicians did not believe 
that ED occurred in certain ethnic groups such as African Americans.100  This along with 
negative attitudes towards professional treatment, doubt, and fear around treatment, and 
personal characteristics of the provider such as language barriers or lack of providers with 
similar ethnic backgrounds can further impede treatment.100,101,104 
 
Financial Cost & Insurance 
 
Inpatient treatment for ED costs on average $30,000 per month while intensive outpatient 
varies between $500 to $2000 per day depending on demographics.106  As of 2016, there were 
only 10 states that require private insurers to cover treatment for AN and BN but OSFED was 
left off coverage.106  A study in 2010, by Horgan et al., found that 22.4% of plans did not cover 
services for ED.107  Insurance carriers place restrictions on mental health care such as lower 
caps on physical health care and limiting the number of days covered in an inpatient treatment 
program.106  Some insurers claim that inpatient and IOP treatment for BN and OSFED are not 
medically necessary and that there is not enough evidence on effective treatments pointing to 
the need for more research.106  Additionally, many of the treatment facilities may be out of 
network leading to higher out of pocket expenses.108 
Conclusion 
 
With multiple physical, nutritional, and psychiatric implications, eating disorders significantly 
decrease the quality of life of those affected and require skilled treatment professionals.  The 
etiology of eating disorders includes genetic, biological, individual, family, psychological, and 
socio-cultural factors.3  Each discipline of the treatment team has unique skills and 
responsibilities concerning their area, however, there is overlap in what each member of the 
treatment team does to promote recovery.  Additionally, the lack of formalized ED screening, 
education, and training among health practitioners potentially adds to continued 
misconceptions, poor diagnosis, and prognosis.  All health practitioners should be educated and 
trained in screening, diagnosis, and referral resources.  As health practitioners require years of 
education and didactic internships, there is an opportunity to address this gap in the university 
and collegiate systems as well as health facilities.  
Methods 
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Video interviews were conducted of 12 healthcare providers, family members, and recovered 
patients in the eating disorder community either in person at EDIN’s corporate office or over 
ZOOM.  Each interview lasted between 30-60 minutes and contained between 10-20 questions.  
After interviews were completed, one video was created based on the feedback from the 
interviewees.  Editing was completed utilizing Adobe Premiere Pro software.  The video was 
approved by the Executive Director of EDIN and uploaded to their website. 
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Appendix 1: LOC Guidelines 
 
Guidelines for Levels of Care for Patients with Eating Disorders 
 Outpatient IOP PHP Residential Inpatient 
Medical Status Stable – extensive monitoring not needed Medically stable 
(not requiring  IV 
fluids, NG tube 
feedings, or 
multiple daily lab 
results 
Adults: HR <40 beats/min; BP <90/60 mm 
HG; glucose < 60 mg/dL; potassium <3 
mEq/L; electrolyte imbalance; 
temperature <97.0F; dehydration, hepatic, 
renal, or cardiovascular organ 
compromise, poorly controlled diabetes 
Children and Adolescents: HR near 40 
beats/min; orthostatic blood pressure 
changes, BP <80/50 mm HG; hypokalemia, 
hypophosphatemia, or hypomagnesemia 
Suicidality If suicidality is present, inpatient monitoring and may be needed 
depending on level of risk 
Plan with lethality or intent; admission of 
suicide attempt depending on presence of 
other factors modulating suicide risk. 
Weight (based 
on % of healthy 
body weight) 
>85% >80% >80% <85% <85%; acute weight decline with food 
refusal even if not <85% 
Motivation Fair to good Fair Partial; 
cooperative; 
preoccupied 
with intrusive 
repetitive 
thoughts 
>3hrs/day 
Poor to fair; 
preoccupied with 
intrusive repetitive 
thoughts 4-6 
hrs/day; 
cooperative with 
structured 
environment 
Very poor to poor; preoccupied with 
intrusive repetitive thoughts; 
uncooperative with treatment or 
cooperative only in highly structured 
environment 
Comorbid 
disorders 
Presence may influence LOC Any existing psychiatric disorder that 
would require hospitalization 
Structure 
Needed 
Self-sufficient Some structure 
needed 
Needs supervision 
at all meals or will 
restrict 
Needs supervision during and after all 
meals or NG/special feeding needed 
Ability to 
Control 
Compulsive 
Exercise 
Ability to 
control 
Can 
manage 
through 
self-
control 
Some degree of external structure required to prevent patient 
Purging 
Behavior 
Can greatly reduce incidents in unstructured 
setting; no significant medical complications 
Can ask for and 
use support from 
others or use CBT 
skills to inhibit 
purging 
Needs supervision during and after all 
meals and in bathrooms; unable to control 
multiple daily episodes of purging that are 
severe and disabling, despite trial of 
outpatient care even if lab results are 
normal 
Environmental 
Stress 
Often able to provide 
adequate emotional and 
practical support and 
structure 
Others able to 
provide at least 
limited support 
and structure 
Severe family conflict or problems or absence of family so unable 
to receive structure environment at home, or patient lives alone 
without adequate support system 
Geographic 
Availability of 
treatment 
Patient lives near treatment setting Treatment programs are too distant for patient to participate 
from home 
HR = heart rate; BP = blood pressure; IV = intravenous; NG = Nasogastric; mm HG = millimeter of mercury; hrs = hours  
Adapted from Anderson LK, Reilly EE, Berner L, et al. Treating Eating Disorders at Higher Levels of Care: Overview and 
Challenges. Curr Psychiatry Rep. 2017;19(8):48 
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Appendix 2: Video Screenshots 
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